Cross-institution positioning
Mar 27, 2026Reduction leaning. 1 accumulating, 1 reducing, 2 exited across 4 comparable institutions.
Source: Schedule 13 researchRCKT Institutional Ownership
ROCKET PHARMACEUTICALS, INC.
Latest stored close $2.56 as of Oct 9, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
36/100
5 tracked · 4 comparable
Latest filing
Mar 27, 2026
Positive breadth
2 positive · 3 negative
Recent close
$2.56
Research confidence
Limited
Institutional Research 23/100 · 1 accumulating · 3 reducing / exited
Ownership history
Reported ownership % history
Latest filing Mar 27, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating1
Newly reported1
Reducing / exited
3
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 36/100
Confidence:Limited
Why this signal
- 1 tracked institution accumulating versus 3 reducing/exited.
- 1 tracked institution shows persistent accumulation.
- Comparable SEC fundamentals are improving.
Conflicting evidence
- Institutions are reducing while comparable SEC fundamentals are improving.
Institutional
30/100
Insiders
22/100
Fundamentals
70/100
Events
50/100
Quarterly 13F activity
Jun 30, 20261 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Sep 11, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 7 sales by 4 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Oct 6, 20266 non-amendment material events in the last 90 days; 2 capital-related filing/events (2 equity-related, 1 debt-related); Latest classified evidence: Material definitive agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 10, 2026Net income +278.8% YoY; Free cash flow +19.1% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 30% through its reported 52-week range; +5.9% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Vanguard Group.
Filed Mar 27, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Mar 27, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
BlackRock
Filed Jan 29, 2024
Direction locked
Vanguard Group
Filed Mar 27, 2026
Direction locked
Wellington Management Group
Filed Jun 5, 2025
Direction locked
State Street
Filed Jan 22, 2024
Direction locked
T. Rowe Price Associates
Filed Feb 14, 2022
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
BlackRock
Filed Jan 29, 2024
Vanguard Group
Filed Mar 27, 2026
Wellington Management Group
Filed Jun 5, 2025
State Street
Filed Jan 22, 2024
T. Rowe Price Associates
Filed Feb 14, 2022
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales32 reporting owner(s)
90-day purchase breadth0
90-day sale breadth4Multi-insider
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Wilson Martin | SOpen-market or private sale | Common Stock | 75.4K | $3.40 | Direct | Sep 15, 2026 |
| Aug 18, 2026 | Shah Gaurav | SOpen-market or private sale | Common Stock | 2.3K | $3.38 | Direct | Aug 20, 2026 |
| Aug 18, 2026 | Wilson Martin | SOpen-market or private sale | Common Stock | 631 | $3.38 | Direct | Aug 20, 2026 |
| Aug 13, 2026 | Wilson Martin | SOpen-market or private sale | Common Stock | 3.5K | $3.38 | Direct | Aug 17, 2026 |
| Aug 13, 2026 | Shah Gaurav | SOpen-market or private sale | Common Stock | 2.8K | $3.38 | Direct | Aug 17, 2026 |
| Aug 11, 2026 | Chaudhuri Sarbani | SOpen-market or private sale | Common Stock | 4.7K | $3.50 | Direct | Aug 13, 2026 |
| Aug 11, 2026 | Stevens Christopher James | SOpen-market or private sale | Common Stock | 36.7K | $3.50 | Direct | Aug 13, 2026 |
| Aug 3, 2026 | SOUTHWELL DAVID P | JOther transaction | Common Stock | 150.0K | $0.00 | Direct | Aug 5, 2026 |
| Aug 3, 2026 | Stevens Christopher James | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 101.4K | $0.00 | Direct | Aug 5, 2026 |
| Aug 3, 2026 | Stevens Christopher James | AGrant, award, or other acquisition | Common Stock | 73.3K | $0.00 | Direct | Aug 5, 2026 |
| Jun 18, 2026 | BOESS CARSTEN | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 64.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | BOESS CARSTEN | AGrant, award, or other acquisition | Common Stock | 22.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | SOUTHWELL DAVID P | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 64.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | SOUTHWELL DAVID P | AGrant, award, or other acquisition | Common Stock | 22.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | Malik Fady Ibraham | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 64.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | Malik Fady Ibraham | AGrant, award, or other acquisition | Common Stock | 22.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | Dolsten Mikael | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 64.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | Dolsten Mikael | AGrant, award, or other acquisition | Common Stock | 22.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | Fong Peter | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 64.9K | $0.00 | Direct | Jul 6, 2026 |
| Jun 18, 2026 | Fong Peter | AGrant, award, or other acquisition | Common Stock | 22.9K | $0.00 | Direct | Jul 6, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events2
90-day capital-related2
90-day equity-related2
90-day debt-related1
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 6, 2026 | 8-K | 1.01, 2.03, 3.02, 7.01, 9.01 | Material definitive agreement; New direct financial obligation; Unregistered sale of equity securities; Regulation FD disclosure; Financial statements / exhibits | Equity | Filing |
| Sep 15, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Aug 27, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Aug 10, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Aug 3, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 14, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jun 30, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jun 12, 2026 | 8-K | 2.01, 7.01, 9.01 | Acquisition or disposition of assets; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 21, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 7, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 28, 2026 | 8-K | 1.01, 7.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Mar 27, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$0
Q2 2026
10-Q filed Aug 10, 2026
Operating income
$-46.9M
Q2 2026
+34.1% YoY 10-Q filed Aug 10, 2026
Net income
$123.2M
Q2 2026
+278.8% YoY 10-Q filed Aug 10, 2026
Diluted EPS
$1.08
Q2 2026
+274.2% YoY 10-Q filed Aug 10, 2026
Operating cash flow
$-85.0M
YTD through Jun 30, 2026
+18.9% YoY 10-Q filed Aug 10, 2026
Free cash flow
$-85.1M
YTD through Jun 30, 2026
+19.1% YoY 10-Q filed Aug 10, 2026
Cash & equivalents
$224.5M
As of Jun 30, 2026
+584.1% YoY 10-Q filed Aug 10, 2026
Assets
$423.1M
As of Jun 30, 2026
+0.5% YoY 10-Q filed Aug 10, 2026
Liabilities
$54.3M
As of Jun 30, 2026
-18.7% YoY 10-Q filed Aug 10, 2026
Stockholders’ equity
$368.8M
As of Jun 30, 2026
+4.1% YoY 10-Q filed Aug 10, 2026
Shares outstanding
109.8M
As of Jul 31, 2026
+1.7% YoY 10-Q filed Aug 10, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $0 | — |
| Ended Mar 31, 2026 | $0 | — |
| Ended Sep 30, 2025 | $0 | — |
| Ended Jun 30, 2025 | $0 | — |
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $0 | — |
| Ended Dec 31, 2024 | $0 | — |
| Ended Dec 31, 2023 | $0 | — |
| Ended Dec 31, 2022 | $0 | — |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$3.41
View live quote ↗
52-week low
$2.53
Jun 9, 2026
52-week high
$5.45
Mar 10, 2026
Below 52-week high
37.4%
1W return
-8.1%
1M return
-1.7%
3M return
+19.2%
6M return
-27.9%
YTD return
-2.8%
1Y return
+5.9%
30-day volatility
55.2%
90-day volatility
59.8%
1Y max drawdown
-50.9%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 26 filing(s) · 23 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Reported reduction | 11 -8.5M | 12.00% +4.11 pts | $4.73 | $3.77 | $2.56 |
| Vanguard Group CIK0000102909 | Dec 31, 2025 observed Jan 30, 2026 filed · 30d Schedule 13G amendment | Reported accumulation | 8.5M +3.1M | 7.89% +1.85 pts | $3.51 | $3.48 | $2.56 |
| Wellington Management Group CIK0000902219 | May 30, 2025 observed Jun 5, 2025 filed · 6d Schedule 13G amendment | Exit below reporting threshold | 1.0M -6.1M | 0.93% -5.78 pts | $2.51 | $2.77 | $2.56 |
Explore more institutional activity
Related research
Compare RCKT with other securities showing similar institutional activity or recent accumulation across several tracked institutions.